BBIO
Eidos Therapeutics To Present Data On Its Potential Treatment For Transthyretin Amyloidosis At The American Heart Association
Thursday, November 9, 2017 1 min read
Key Takeaway: Eidos Therapeutics To Present Data On Its Potential Treatment For Transthyretin Amyloidosis At The American Heart Association
Full Press Release Details
Eidos Therapeutics To Present Data On Its Potential Treatment For Transthyretin Amyloidosis At The American Heart Association.